The insurability of innovative pharmaceutical cancer technologies

Abstract The scientific literature, including several papers published in the IJHPR, has raised the issue of the spiraling cost of cancer treatment, including that of cancer drugs and other technologies such as gene and cell therapies. In this perspective, we review three criteria for insurability a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shuli Brammli Greenberg (Auteur), Einat Dotan (Auteur), Rachel Arazi (Auteur)
Format: Livre
Publié: BMC, 2020-12-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible